IP Library Granted Patent US 8,733,350
Granted Patent B2
US 8,733,350 · App. 12/546,260 · Granted May 27, 2014

Medthods, devices and formulations for targeted endobronchial therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,733,350
App. No.
12/546,260
Granted
May 27, 2014
Kind
B2
Abstract

The present invention provides an improved means of treating tracheobronchitis, bronchiectasis and pneumonia in the nosocomial patient, preferably with aerosolized anti gram-positive and anti-gram negative antibiotics administered in combination or in seriatim in reliably sufficient amounts for therapeutic effect. In one aspect, the invention assures this result when aerosol is delivered into the ventilator circuit. In one embodiment the result is achieved mechanically. In another embodiment, the result is achieved by aerosol formulation. In another aspect, the invention assures the result when aerosol is delivered directly to the airways distal of the ventilator circuit. The treatment means eliminates the dosage variability that ventilator systems engender when aerosols are introduced via the ventilator circuit. The treatment means also concentrates the therapeutic agent specifically at affected sites in the lung such that therapeutic levels of administrated drug are achieved without significant systemic exposure of the patient to the drug. The invention further provides a dose control device to govern this specialized regimen.

Claims (12)

1. A method of treating patients in an ICU, comprising:

a) identifying a mechanically ventilated patient in said intensive care unit being treated with a systemic antibiotic, and

b) administering, in addition, an aerosolized antibiotic to said patient by means of an aerosolizing device.

2. The method of claim 1 , wherein a plurality of subjects in the same intensive care unit is being treated with aerosolized antibiotic.

3. The method of claim 2 , wherein treating said plurality of subjects in said ICU reduces the incidence of antibiotic-resistant infection in said ICU.

4. The method of claim 1 , wherein a plurality of subjects in the same intensive care unit is being treated with both systemic and aerosolized antibiotics.

5. The method of claim 4 , wherein treating said plurality of subjects in said ICU reduces the incidence of antibiotic-resistant infection in said ICU.

6. A method of treating patients in an ICU, comprising:

a) providing a device capable of delivering aerosolized antibiotic, and

b) administering said aerosolized antibiotic to a mechanically ventilated patient in said intensive care unit with said device, wherein a plurality of subjects is treated in the same intensive care unit with both systemic and aerosolized antibiotics.

7. The method of claim 6 , wherein treating said plurality of subjects in said ICU reduces the incidence of antibiotic-resistant infection in said ICU.

8. The method of claim 1 , wherein said administering is performed while said patient is mechanically ventilated.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2009
From: SMALDONE, GERALD C.; PALMER, LUCY B.
To: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
Reel/Frame 023275/0219 →